Effect of Tamsulosin on Prostate
Phase 2
Recruiting
- Conditions
- Benign prostatic hyperplasia.Hyperplasia of prostate
- Registration Number
- IRCT20160514027893N3
- Lead Sponsor
- Bojnourd University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Male
- Target Recruitment
- 80
Inclusion Criteria
All patients with LUTS (Lower Urinary Tract Symptoms) who need tamsulosin drug and are satisfied.
Exclusion Criteria
having prostat surgery history
tamsulosin consumption history
unsatisfication
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Reducing the amount of international prostate symptom score (IPSS). Timepoint: Measuring IPSS at the beginning of the study (before the intervention) And 8 weeks after the start of taking tamsulosin capsules. Method of measurement: International prostate symptom score (IPSS).
- Secondary Outcome Measures
Name Time Method